Lactic Acid Downregulates Viral MicroRNA To Promote Epstein-Barr Virus-Immortalized B Lymphoblastic Cell Adhesion and Growth
- 1 May 2018
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (9), e00033-18
- https://doi.org/10.1128/jvi.00033-18
Abstract
High plasma lactate is associated with poor prognosis of many malignancies, but its role in virally mediated cancer progression and underlying molecular mechanisms are unclear. Epstein-Barr virus (EBV), the first human oncogenic virus, causes several cancers, including B-cell lymphoma. Here, we report that lactate dehydrogenase A (LDH-A) expression and lactate production are elevated in EBV-immortalized B lymphoblastic cells, and lactic acid (LA; acidic lactate) at low concentration triggers EBV-infected B-cell adhesion, morphological changes, and proliferation in vitro and in vivo. Moreover, LA-induced responses of EBV-infected B cells uniquely occurs in viral latency type III, and it is dramatically associated with the inhibition of global viral microRNAs, particularly the miR-BHRF1 cluster, and the high expression of SMAD3, JUN, and COL1A genes. The introduction of miR-BHRF1-1 blocks the LA-induced effects of EBV-infected B cells. Thus, this may be a novel mechanism to explain EBV-immortalized B lymphoblastic cell malignancy in an LA microenvironment. IMPORTANCE The tumor microenvironment is complicated, and lactate, which is created by cell metabolism, contributes to an acidic microenvironment that facilitates cancer progression. However, how LA operates in virus-associated cancers is unclear. Thus, we studied how EBV (the first tumor virus identified in humans; it is associated with many cancers) upregulates the expression of LDH-A and lactate production in B lymphoma cells. Elevated LA induces adhesion and the growth of EBV-infected B cells by inhibiting viral microRNA transcription. Thus, we offer a novel understanding of how EBV utilizes an acidic microenvironment to promote cancer development.Funding Information
- National Key Research and Development Program of China (2016YFC1200400)
- National Natural Science Foundation of China (81471930)
- National Natural Science Foundation of China (81672015)
This publication has 51 references indexed in Scilit:
- Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor CellsPLOS ONE, 2012
- Epstein-Barr Virus Immortalization of Human B-Cells Leads to Stabilization of Hypoxia-Induced Factor 1 Alpha, Congruent with the Warburg EffectPLOS ONE, 2012
- The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell LinesPLoS Pathogens, 2012
- IKKβ and NF-κB Transcription Govern Lymphoma Cell Survival through AKT-Induced Plasma Membrane Trafficking of GLUT1Cancer Research, 2011
- The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B LymphocytesJournal of Virology, 2011
- Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B CellsPLoS Pathogens, 2010
- Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer CellsOnline Journal of Public Health Informatics, 2008
- EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3Cancer Research, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- On the Origin of Cancer CellsScience, 1956